Adaptimmune Therapeutics plc (ADAPY) Earnings Call Transcripts

35 earnings calls from February 2020 to May 13, 2025

OTC Pink Market US Health Care

Below are every Adaptimmune Therapeutics plc (ADAPY) earnings call transcript on record at EarningsCalls.dev, covering 35 quarters of the company's results in the Health Care sector. Each entry links to the full free-reading transcript with speaker segments, key metrics and an AI-generated summary. The same data is available via our REST API.

Quarter Date
Q1 FY2025 May 13, 2025 Read transcript →
Q4 FY2024 Mar 20, 2025 Read transcript →
Company Conference Presentations Jan 15, 2025 Read transcript →
Special Calls Nov 18, 2024 Read transcript →
Q3 FY2024 Nov 13, 2024 Read transcript →
Q2 FY2024 Aug 12, 2024 Read transcript →
Special Calls Aug 2, 2024 Read transcript →
Special Calls May 31, 2024 Read transcript →
Q1 FY2024 May 15, 2024 Read transcript →
Analyst/Investor Day Apr 18, 2024 Read transcript →
Q4 FY2023 Mar 6, 2024 Read transcript →
Company Conference Presentations Jan 11, 2024 Read transcript →
Q3 FY2023 Nov 8, 2023 Read transcript →
Q2 FY2023 Aug 9, 2023 Read transcript →
Special Calls Jun 2, 2023 Read transcript →
Q1 FY2023 May 12, 2023 Read transcript →
Q4 FY2022 Mar 6, 2023 Read transcript →
Q3 FY2022 Nov 8, 2022 Read transcript →
Q2 FY2022 Aug 4, 2022 Read transcript →
Q1 FY2022 May 9, 2022 Read transcript →
Q4 FY2021 Mar 14, 2022 Read transcript →
Company Conference Presentations Feb 17, 2022 Read transcript →
Q3 FY2021 Nov 4, 2021 Read transcript →
Special Calls Sep 9, 2021 Read transcript →
Q2 FY2021 Aug 9, 2021 Read transcript →
Q1 FY2021 May 6, 2021 Read transcript →
Q4 FY2020 Feb 25, 2021 Read transcript →
Company Conference Presentations Jan 14, 2021 Read transcript →
Analyst/Investor Day Nov 20, 2020 Read transcript →
Q3 FY2020 Nov 5, 2020 Read transcript →
Company Conference Presentations Sep 17, 2020 Read transcript →
Company Conference Presentations Sep 9, 2020 Read transcript →
Q2 FY2020 Aug 6, 2020 Read transcript →
Q1 FY2020 May 14, 2020 Read transcript →
Q4 FY2019 Feb 27, 2020 Read transcript →